Rheumatological disorders and auto immune diseases form the bulk of Immune related diseases that globally impact a large number of people.
Rheumatological disorders comprise of over 150 diseases and syndromes, which are progressive and painful to the patient. Out of these arthritis of various joints affects ~ 15% (0ver 180 million) Indian population.1 The prevalence of arthritis is higher than other common diseases such as metabolic/oncologic diseases. These diseases are treated by Rheumatologist.
- Spondyloarthropathies (Ankylosing, Psoriatic and etc..)
- Juvenile Idiopathic Arthritis
- Crystal Arthropathies (Gout)
- Lupus, Scleroderma
- Sjogren’s Syndrome
Biologics and Biosimilars play an important role in the rheumatology segment. and is one of the fastest emerging therapy areas in the rheumatology segments. Biosimilars will increase the access to and expand the use of biologics, which may lead to better overall health outcomes as well as savings and efficiencies to the health care system.